Products & Services

NMNH

NMNH

Compound name:  β-nicotinamide mononucleotide, reduced form, disodium salt

Molecular formula:  C11H17N2O8P

Molecular weight:  336.24 g/mol

CAS No.:  108347-85-9

NMNH Introduction

Dihydro nicotinamide mononucleotide (NMNH) is the reduced-form of nicotinamide mononucleotide (NMN), which was naturally occurred in kidney, act as a better NAD+ enhancer compared to NMN. NMNH could convert to NAD+ rapidly in vivo, which is two times higher than NMN in speed and concentration,and also increase the NAD+ level in a variety of tissues. NMNH could reduce cell damage under hypoxia condition by enhancing repair. In addition, Additionally, NMNH increased the NADH level in cells and in mouse liver, suppresses glycolysis and TCA cycle.

Bontac Bio-engineering competitive advantages:

  • The world's leading Kosher-certified coenzyme manufacturer<br/> In 2014, Bontac took the lead in realizing the industrialization of NMN<br/> In 2021, Bontac achieve the world's first massive production of NMNH

    The world's leading Kosher-certified coenzyme manufacturer
    In 2014, Bontac took the lead in realizing the industrialization of NMN
    In 2021, Bontac achieve the world's first massive production of NMNH

  • Perfect quality control system<br/> More than 40 high-precision imported testing equipment and dozens of testing indicators

    Perfect quality control system
    More than 40 high-precision imported testing equipment and dozens of testing indicators

  • Excellent green bio-enzyme catalytic synthesis technology platform<br/> Unique enzymatic technology, Free acid type or sodium salt type of NMNH

    Excellent green bio-enzyme catalytic synthesis technology platform
    Unique enzymatic technology, Free acid type or sodium salt type of NMNH

  • Joint Research Centre with numerous internationally well-known universities<br/> Provide high-quality research materials for more than 30 research institutions worldwide

    Joint Research Centre with numerous internationally well-known universities
    Provide high-quality research materials for more than 30 research institutions worldwide

  • Obtained more than 10 NMN related patents at home and abroad<br/> Hundreds of independently developed enzyme catalysis-related invention patents and international patent applications

    Obtained more than 10 NMN related patents at home and abroad
    Hundreds of independently developed enzyme catalysis-related invention patents and international patent applications

  • Always adhere to the whole-enzyme catalytic production, stable quality, high safety<br/> Upgrade of coenzyme production line 3rd generation  enzyme catalysis technology was implemented, Coenzyme production expand to annual output of 100 tons

    Always adhere to the whole-enzyme catalytic production, stable quality, high safety
    Upgrade of coenzyme production line 3rd generation enzyme catalysis technology was implemented, Coenzyme production expand to annual output of 100 tons

Sample Application

Sample Application